| Serial Number | 97367616 |
| Word Mark | CELMOD |
| Filing Date | Monday, April 18, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, July 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 16, 2023 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 22, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Thursday, April 21, 2022 | NEW APPLICATION ENTERED |
| Friday, April 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 29, 2022 | ASSIGNED TO EXAMINER |
| Friday, October 7, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, October 7, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, October 7, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 7, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 10, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 26, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 16, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 16, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 11, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, January 10, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, January 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 11, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, July 11, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, January 10, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, January 10, 2024 | SOU EXTENSION 1 FILED |